Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Kadimastem (OTC : KMSTF) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.
Quote
| Last: | $5.06 |
|---|---|
| Change Percent: | 100.0% |
| Open: | $0 |
| Close: | $5.06 |
| High: | $0 |
| Low: | $0 |
| Volume: | 1,600 |
| Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Stock Data
| Market Cap: | $184,218,140 |
|---|---|
| Float: | 36,406,747 |
| Insiders Ownership: | N/A |
| Institutions: | |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Country: | IL |
| City: |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Kadimastem (OTC: KMSTF).
